Landiolol
HealthData.Gov
Updated Mar 23, 2026
About this dataset
Rapibylk (landiolol hydrochloride) is an intravenous prescription medication used as a beta-blocker to help control rapid heart rate. It comes as a lyophilized powder in a single-dose vial, equivalent to 280 mg of landiolol base, manufactured by AOP Orphan Pharmaceuticals GmbH. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Landiolol
Access the FDA dataset for Landiolol — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025